News - Hyperion Therapeutics


Current filters:

Hyperion Therapeutics

Popular Filters

SOBI gains rights to distribute Ravicti in Middle East


Swedish Orphan Biovitrum says Hyperion Therapeutics has granted it exclusive rights to distribute its…

Genito-urinaryHyperion TherapeuticsLicensingPharmaceuticalRavictiRest of the WorldSobiSwedish Orphan Biovitrum

Regulatory news for Hyperion's Ravicti and Seattle Genetics' Adcetris


The US Food and Drug Administration on Friday approved Hyperion Therapeutics' (Nasdaq: HPTX) Ravicti…

AdcetrisBiotechnologyHyperion TherapeuticsNorth AmericaOncologyPatentsPharmaceuticalRare diseasesRavictiRegulationSeattle Genetics

Hyperion gets rights to Ravicti, and perhaps more, from Ucyclyd


Privately-held US firm Hyperion Therapeutics has acquired worldwide rights to the investigational drug…

AmmonulBuphenylGastro-intestinalsHyperion TherapeuticsLicensingMedicis PharmaceuticalNephrology and HepatologyPharmaceuticalRavictiUcyclyd Pharma

Back to top